Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 12/03/2010 logo of mtm

    mtm laboratories announces the European launch of CINtec® PLUS

    mtm laboratories, a privately held diagnostics company from Heidelberg, Germany, announced the launch of CINtec® PLUS, the company’s next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer. CINtec® PLUS will be launched with claims direct in Germany, Italy, Spain, France and the UK, and will also be available in other parts of the world via mtm’s nominated distributors.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mtm-laboratories-announces-the-european-launch-of-cintec-plus
  • Press release - 04/03/2010 10810_de.jpg

    New German-Austrian project for breast cancer therapy

    Hope for breast cancer patients under the leadership of the Vorarlberg Institute for Vascular Investigation and Treatment VIVIT a cross border cooperation is to start between hospitals and bioanalytical laboratories of the Rhine Valley and Lake Constance region. It is aimed at exploring the influence genetic material DNA has on the progression of breast cancer and the response to breast cancer treatment. A collaboration which became possible…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-german-austrian-project-for-breast-cancer-therapy
  • Article - 22/02/2010 10696_de.jpg

    Treasure trove of data from Ulm helps in the understanding of community-acquired pneumonia

    CAP community-acquired pneumonia is a common type of pneumonia that mainly affects young and old people. In Germany around 800000 people contract CAP every year and almost one third has to be admitted to hospital exceeding the number of admissions due to cardiac infarction or stroke. The CAPNETZ competence network which up until recently was funded by the German government is gradually shedding light on a hitherto little known disease.

    https://www.gesundheitsindustrie-bw.de/en/article/news/treasure-trove-of-data-from-ulm-helps-in-the-understanding-of-community-acquired-pneumonia
  • Press release - 18/02/2010 10739_de.jpg

    New molecules promise improved diagnosis of pancreatic cancer

    Being diagnosed with pancreatic cancer is often a death sentence. One reason for the high mortality rate of pancreatic cancer patients is that there is currently no reliable diagnosis of early stages and no cure once the disease has reached a late stage. In an EU-funded project, 23 research groups from six countries have developed new strategies for the improved diagnosis of pancreatic cancer. Researchers at the Ulm-based Hospital for Nuclear…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-molecules-promise-improved-diagnosis-of-pancreatic-cancer
  • Press release - 04/02/2010 New partners: Klaus Haberstroh, CEO of ESE GmbH and Dr. Michael Collasius, Vice President Automated Systems of QIAGEN Instruments AG, holding one of the ESE instruments.

    QIAGEN acquires ESE GmbH

    QIAGEN N.V. has announced its acquisition of ESE GmbH a privately owned developer and manufacturer of UV and fluorescence optical measurement devices. ESE GmbH is based in Stockach Germany. The cash transaction is valued at up to US19 million.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/qiagen-acquires-ese-gmbh
  • Press release - 04/02/2010 10640_de.jpg

    World Cancer Day: encouraging the prevention, detection and treatment of cancer

    World Cancer Day on the 4th of February is designed to raise awareness that cancer remains one of the major, often fatal human diseases. Every year, more than twelve million people worldwide develop cancer. The Helmholtz Association carries out research into the development of cancer and the underlying risk factors, and comes up with effective strategies for the prevention of cancer and for better diagnostics and targeted therapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/world-cancer-day-encouraging-the-prevention-detection-and-treatment-of-cancer
  • Press release - 28/01/2010 Roche Logo

    Roche invests 86 million Swiss Francs in its Mannheim site

    Roche is to invest 86 million Swiss Francs (approximately 57.3 million euros) in the construction of a new pharmaceutical production unit at its Mannheim company site. The new production line will deliver the commercial supply of the breast cancer drug Herceptin (trastuzumab) from 2013 onwards.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/roche-invests-86-million-swiss-francs-in-its-mannheim-site
  • Press release - 26/01/2010 The photo shows the Leading Edge Cluster winners together with Research Minister Prof. Dr. Annette Schavan.<br />

    MicroTEC Südwest convinces in the second round of the BMBF’s Leading Edge Cluster competition

    The winners of the second round of the German Federal Ministry of Education and Research’s (BMBF) Leading Edge Cluster competition have now been selected. On 26th January 2010, the chairman of the jury, Prof. Dr. Andreas Barner (spokesperson for the Boehringer Ingelheim GmbH Management Board), and the German Research Minister, Prof. Dr. Annette Schavan, announced in Berlin which of the ten finalists of the highly lucrative Leading Edge Cluster…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/microtec-suedwest-convinces-in-the-second-round-of-the-bmbf-s-leading-edge-cluster-competition
  • Article - 25/01/2010 Prof. Dr. Martin Elmlinger and his colleague Marion Eisenhauer in the laboratory. Elmlinger is holding a ball-pen in his hand, pointing at a microtitre plate Marion Eisenhauer is holding in her hand.<br />

    Intelligent use of suitable biomarkers

    How quickly does a pharmaceutical substance exert its effect? What mechanisms does it use to exert its effect on people and how long does it remain active? In a team headed by Prof. Dr. Martin Elmlinger Nycomed GmbH has developed an efficient biomarker discovery concept specially adapted to the companys requirements and designed to clarify such questions. The concept is specifically geared to the phases and requirements of the companys projects.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/intelligent-use-of-suitable-biomarkers
  • Article - 25/01/2010 10570_de.jpg

    Treatment and Research Centre of Rare Diseases established in Tübingen

    On 22nd January 2010, the first German Treatment and Research Centre of Rare Diseases (ZSE) was officially opened in Tübingen. Interdisciplinary teams will from now on be developing new therapies under one roof for around three to four million patients suffering from rare diseases in Germany. The centre in Tübingen will offer optimal patient treatment, coordinate the cooperation between international specialists, and provide competent advice and…

    https://www.gesundheitsindustrie-bw.de/en/article/news/treatment-and-research-centre-of-rare-diseases-established-in-tuebingen
  • Press release - 18/01/2010 The photo shows the new screening method involving an automated Raman spectroscope developed by the Fraunhofer IPM. The method enables the rapid and precise characterisation of bacteria.<br />

    Measurement instead of culture – rapid detection of Legionella

    There has been an unusually high frequency of Legionella infections in the city of Ulm in the period since mid-December 2009. The search for the source of the infection is well underway, although the use of traditional detection methods make it a time-consuming process. New screening methods developed by the Fraunhofer IPM could considerably reduce the time required to detect the source of infection.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/measurement-instead-of-culture-rapid-detection-of-legionella
  • Article - 14/12/2009 10386_de.jpg

    Clever surveillance system keeps yeast in check

    The spectrum of human diseases (mycoses) caused by fungi ranges from trivial nail infections to life-threatening systemic infections. The latter are mainly caused by Candida albicans. The dermatologist Prof. Dr. med. Martin Schaller from Tübingen is investigating how this fungus, which is actually part of the normal microbial flora of humans, becomes a pathogen. At the same time, he is looking into the role the patient’s immune system plays in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/clever-surveillance-system-keeps-yeast-in-check
  • Press release - 08/12/2009 10367_de.jpg

    Official opening of the BioRN Academy in Mannheim

    On 7th December 2009, the BioRN Academy was opened with an official ceremony at the MAFINEX Technology Centre in Mannheim, Germany. This marks the beginning of a project, which is the only one of its kind in Germany, aimed at the further qualification of life scientists as managers in the biotechnology industry. The Rhine-Neckar Graduate School, Graf & Associate, Roche Diagnostics and the SRH University of Applied Sciences Heidelberg are all…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/official-opening-of-the-biorn-academy-in-mannheim
  • Press release - 07/12/2009

    Curetis AG - € 18.5 million Series A Financing Round closed

    A consortium of leading life-science venture capital funds invests € 18.5 million in the German medical diagnostics company Curetis AG. This financing will enable Curetis to complete development of its innovative diagnostic products through to market entry.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curetis-ag-18-5-million-series-a-financing-round-closed
  • Article - 30/11/2009 10180_de.jpg

    BioPharMaXX cluster to strengthen the Ulm region

    BioRegionUlm recently announced the launch of BioPharMaXX at a meeting held in Ummendorf castle (close to Ulm). The acronym refers to a cluster focusing on biotechnology, pharmacy and medical technology that was selected as one of twelve regional clusters in a state-wide contest in Baden-Württemberg in 2008. Company representatives and researchers presented projects to improve the time-consuming and costly protein purification process used in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/biopharmaxx-cluster-to-strengthen-the-ulm-region
  • Article - 28/11/2009 Two men sitting at a table.

    "You cannot afford to fail twice in Germany"

    Prof. Dr. Bodo Liedvogel and Dr. Heinz Haubruck founded the company DIARECT AG in Freiburg in 1998. They not only brought 20 years of experience in industry to the company but also their entire savings. In the following interview Dr. Heinz Haubruck tells Christoph Bächtle about the return investors expect from companies how to win over potential clients and the risks associated with setting up ones own business.

    https://www.gesundheitsindustrie-bw.de/en/article/news/you-cannot-afford-to-fail-twice-in-germany
  • Press release - 24/11/2009 08652_de.jpg

    Three new collaborative research centres in Baden-Württemberg

    The German Research Foundation (DFG) is set to establish 17 new collaborative research centres (SFBs) on 1st January 2010. Ten of the new SFBs will focus on life science research projects, and will initially be funded for a period of four years with a total of 78 million euros in funding. One of the SFBs will be established at the University of Freiburg. Six of the 17 new SFBs are SFB/Transregio projects involving researchers from several German…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/three-new-collaborative-research-centres-in-baden-wuerttemberg
  • Press release - 23/11/2009 GATC Biotech AG Logo

    GATC Biotech soon opens sequencing laboratory in London

    GATC Biotech Europes leading sequencing service provider for industrial and academic research announces that it will open a sequencing laboratory in London to provide scientists in UK and Ireland with single sample sequencing services. The GATC London Laboratory will be situated in the London BioScience Innovation Centre LBIC and will start operations on January 4 2010.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-soon-opens-sequencing-laboratory-in-london
  • Article - 05/11/2009 Dr. Hanswilly Müller operates the blue-framed touch screen of the CLAIR device.

    CLAIR provides new insights

    The human eye is a fascinating organ as well as model for the specialists at Stockach-based Sensovation AG. Their complex optical detection systems are based on CCD and CMOS technologies. However a high-tech sensor is able to recognise much more than many eyes put together.

    https://www.gesundheitsindustrie-bw.de/en/article/news/clair-provides-new-insights
  • Press release - 27/10/2009 Portrait of Prof. Dr. Andreas von Deimling

    Precision Diagnosis of Brain Tumors: Antibody to Detect Enzyme Defect

    More than 100 different types of brain tumor are known in medicine. Their exact diagnosis is often difficult, because only tiny amounts of tumor tissue are usually available. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the University of Heidelberg have developed an antibody which is highly specific for the characteristic alteration of an enzyme that is typical of two dangerous types of brain tumor.…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/precision-diagnosis-of-brain-tumors-antibody-to-detect-enzyme-defect
  • Press release - 20/10/2009

    2nd Science to Market Conference

    The second Science to Market Conference took place in Hannover, Germany, on October 6 – 7, 2009. The aim of the conference was the promotion of cooperation between academia and industry in the area of pharmaceutical biotechnology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/2nd-science-to-market-conference
  • Press release - 14/10/2009 logo of mtm

    mtm laboratories Extends Series C Financing Round by EUR 7 Million Bringing Total to EUR 39 Million (USD 57 Million)

    mtm laboratories, a privately held diagnostics company developing, manufacturing and globally commercializing in vitro diagnostics for cervical cancer early detection and diagnosis, announced on 14th October the signing for an additional tranche of Euro 7 million to its Series C funding. This addition is a formal expansion of the Company’s last Series C in March 2008 and increases the total for the round to Euro 39 million (USD 57 million) in…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mtm-laboratories-extends-series-c-financing-round-by-eur-7-million-bringing-total-to-eur-39-million
  • Press release - 30/09/2009 Portrait of a woman

    New managing director for BioRegion Rhein-Neckar-Dreieck e.V.

    Biotech expert Dr. Julia Schüler is leaving Ernst Young to join BioRegion Rhein-Neckar-Dreieck e.V. Rhine-Neckar BioRegion. The biologist is to succeed Ernst-Dieter Jarasch the associations managing director since its establishment in 1996.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-managing-director-for-bioregion-rhein-neckar-dreieck-e-v
  • Press release - 24/09/2009 09679_de.jpg

    CeGAT: Tracking genes using cutting-edge technologies

    To adequately meet the growing demand for genetic diagnostics doctor scientist and bioinformatician Dr. Saskia Biskup and her husband business graduate Dr. Dirk Biskup founded the Center for Genomics and Transcriptomics or CeGAT for short in July 2009. As a supplier of DNA and RNA sequencing in the STERN BioRegion CeGAT which is based in the Technology park Tübingen Reutlingen TTR uses state-of-the-art high-throughput technologies to examine…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cegat-tracking-genes-using-cutting-edge-technologies
  • Press release - 18/09/2009

    Why don’t brain tumours respond to drugs?

    Malignant brain tumours do not often respond to promising new drugs. Researchers from Heidelberg have now uncovered a mechanism and a tumour marker that are linked to the development of this resistance. A “death receptor” might possibly indicate the chances of success of chemotherapy at the same time as providing new approaches for developing a new therapy for the successful treatment of brain tumours.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/why-don-t-brain-tumours-respond-to-drugs

Page 14 / 18

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search